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Abstract
We examined the biological activities of a selected sample (84 crude extracts) of 24 species eaten by wild 
chimpanzees (Pan troglodytes schweinfurthii) in the Kibale National Park, western Uganda, to assess
their potential chemotherapeutic values. Antibacterial, antimalarial, and/or antileishmania activities were 
observed in some crude extracts, and ﬁve of these extracts showed a signiﬁcant cytotoxicity against human
tumor cells. Active compounds isolated from three plant parts occasionally ingested by chimpanzees 
(Diospyros abyssinica (Ebenaceae) bark, Uvariopsis congensis (Annonaceae) leaves, and Trichilia 
rubescens (Meliaceae) leaves) showed highly signiﬁcant medicinal properties. Two novel antiparasitic 
limonoids were isolated Trichilia rubescens and their molecular structures were determined. In addition to 
elucidating the natural equilibrium maintained between hosts and pathogens, our investigation of the diet 
of wild chimpanzees may serve as a guideline to discovering plants with bioactive properties that should be 
preserved from destruction because of their health maintenance value for great ape populations
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INTRODUCTION
 In order to fully appreciate and understand primate foraging behavior and plant selection criteria, 
recent studies have looked at the macronutrient and minerals content of items in the diet [e.g. Conklin-
Britain & Wrangham, 1994; Conklin-Brittain et al., 1998; Chapman et al., 2003; Rode et al., 2003].  
Behavioral, ecological and pharmacological studies have also shown the great ape diet to contain a variety 
of plant parts of no apparent nutritional signiﬁcance that may be consumed because of their secondary 
compounds [e.g. Wrangham & Waterman, 1983; Jisaka et al. 1992; Koshimizu et al., 1993; Huffman et 
al., 1998a; Wrangham et al., 1998]. The possibility that some of these dietary plants also have medicinal 
properties has been suggested [Ohigashi et al., 1994; Huffman et al., 1998a, b; Huffman, 2003]. Chemical 
investigations of the medicinal hypothesis have focused mainly on the consequences of two types of 
non-nutritional ingestion by chimpanzees, i.e. ingestion of items that appear to be of little or no nutritive 
signiﬁcance. These are (1) swallowing whole leaves of various species, and (2) ingesting the bitter pith of 
Vernonia amygdalina [Wrangham & Nishida, 1983; Huffman & Seifu, 1989; Wrangham & Goodall, 1989]. 
The antiparasitic properties of the plants ingested by chimpanzees in these cases were also investigated 
[Jisaka et al., 1992; Jisaka et al., 1993; Huffman et al., 1993; Koshimizu et al., 1994; Ohigashi et al., 1994; 
Huffman et al., 1996b;]. While leaf-swallowing has been convincingly implicated as an agent of parasite 
expulsion [Huffman et al., 1996; Huffman & Caton, 2001] and might be involved in alleviating digestive 
pain caused by parasites [Wrangham, 1995], its known effects are due to physical rather than chemical 
causes [Huffman et al., 1996; 1997; Page et al., 1997; Huffman & Caton, 2001]. Messner & Wrangham 
[1996] for example tested the in vitro anthelmintic activity of Rubia cordifolia rough leaves but no 
signiﬁcant activity was observed. Bitter-pith-chewing, on the other hand, has been shown to have potential 
pharmacological consequences based on chemical compounds apparently responsible for the control of 
nematode infections [Koshimizu et al., 1993; Huffman et al., 1993; Ohigashi et al., 1994; Huffman et al., 
1996a]. Furthermore, it has been suggested that compounds found in the ordinary diet of animals may have 
important positive effects on health and may prevent risks of infection and illness [Janzen, 1978; Huffman, 
1997; Huffman et al., 1998a]. This hypothesis is supported by the study of Vitazkova et al. [2001] where 
mice repeatedly sampled bitter substances as a likely feeding strategy for achieving chemoprophylaxis 
against parasite-related diseases. Mice infected by malaria parasites and mice that were not infected 
spontaneously ingested the amount of chloroquine sufﬁcient to contain the infection, even if the solution 
was unpalatable. Even if naturally occurring plants with bitter taste are sometimes poisonous, by sampling 
a variety of bitter substances in small amounts, animals may reduce the likelihood of ingesting lethal doses 
and increase the chance of ingesting a plant with medicinal prophylactic value. We studied the chemistry of 
the plant diet of chimpanzees so as to assess its possible pharmacological value. 
 Our goal was to screen biological properties of plant species from Kibale National Park, Uganda that 
may be of beneﬁt to the health of chimpanzees. In addition, this approach offers the opportunity to describe 
important secondary compounds in the chimpanzee diet, including isolation of any previously undescribed 
natural compounds. As part of our survey of secondary compounds in the diet of chimpanzees, species ingested 
by chimpanzees were investigated and different tissues (bark, leaves, fruits or ﬂowers) were tested even if not 
consumed. This was done for three reasons. One reason for this is the necessity to fully understand the criteria 
of plant selection of Kanyawara chimpanzees, a second reason is to take into account the potential differences 
in consumption of plants according to study site [Goodall, 1986] and the use by other animal species, and a 
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ﬁnal reason is to provide a better knowledge of plant species, an important natural resource which should be 
preserved for the health of both local animals and humans. The use of plant products is today common to both 
traditional and western medicine. New approaches are needed in the search for drugs to combat widespread 
infectious diseases such as malaria, leishmania and cancer. Such a study also provides a database for researchers 
working on different primate species eating the same plant species and emphasizes the necessity of large-scale 
screening.  Based on previous ﬁndings (Huffman et al., 1998a), in an attempt to highlight potentially the most 
biologically active plant parts in the diet of chimpanzees, those items ingested rarely, or only in small amounts, 
were collected.  Another rational for focusing on rarely ingested items in the diet is the ‘dose dependent’ 
distinction made between poison and medicine. Our criteria of selection was used as a simple guideline, and 
is not intended to represent an absolute measure of a plant’s medicinal value to chimpanzees.  Plant materials 
collected were tested for their pharmacological properties against parasites, bacteria, and yeasts. In order to 
test the hypothesis of the potential effect of plant ingestion on health, we monitored chimpanzee health non-
invasively by using feces and urine analysis, veterinary diagnosis and behavioral observations [Krief et al., 
2005, in press]. The levels of activity and the context of consumption may help to highlight different aspects 
of potential medicinal effects of the plants ingested.
METHODS 
Study site
This study was conducted in the Kibale National Park, between December 2000 and March 2001 
(dry season), and in October 2001 (rainy season). The park, located between 0°13’to 0°41’N and 30°19’to 
30°22’E, occupies 795 km
2
 of mid-altitude moist forest, secondary forest, grassland, swamps and plantations 
of Eucalyptus and pines and it includes elements of lowland tropical rainforest, montane rainforest and mixed 
deciduous rainforest. The elevation is between 800 and 1500 m, and the rainfall averages 1700 mm per year. 
Behavioral observations
SK observed the habituated Kanyawara community of chimpanzees (Pan troglodytes schweinfurthii) 
including about 50 individuals, with 10 adult males and 16 adult females. We recorded feeding observations 
by 10-min focal-animal sessions and ad libitum observations during particular sequences related to possible 
medicative behaviour especially of sick chimpanzees and for ingestion of items rarely eaten and/or that 
appeared most likely non-nutritional. In total, 3864 focal sessions were collected. Health state was monitored 
daily with non-invasive methods [Krief et al., 2005 in press]. 
Veterinary survey
Veterinary work consisted of daily clinical observations (respiratory, digestive, reproductive, urinary 
functions, and locomotion). Intestinal parasite evaluation was carried out by examination of feces. When 
following the focal animal throughout the day, particular attention was paid to any abnormal behavioral 
activity, especially clear signs of potential illness such as decreased appetite, long and frequent resting, 
sneezing, coughing or intestinal disorder, as described by Huffman et al. [1997]. Whenever possible, feces 
were collected from all individuals clearly identiﬁed.
Fecal samples were inspected immediately after discharge to check for the presence of macroscopic 
parasites, then collected and stored individually in vials, a part being stored in formalin. Fresh samples were 
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analyzed microscopically using the MacMaster ﬂotation method, and a direct method to ascertain the load and 
species present was applied to the formalin samples, as described by Krief et al. [2003].
A total of 252 dung samples from identiﬁed chimpanzees were collected, including 187 samples 
collected during the dry season and 65 during the rainy season. These samples came from 38 individuals, 
mainly adults (127 samples from 18 females and 125 samples from 20 males).
 
Plant collection
Our plant collection was based on the observation that some types of food appeared more likely than 
others to have medicinal effects, i.e.: (1) bark, which appears to provide minimal nutritional gain and seems 
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energetically costly to remove from the tree; (2) rough-surfaced leaves (e.g. Ficus exasperata and Ficus 
asperifolia) which could have physical properties important for parasite expulsion;  (3) plants with spines 
like Chaetacme aristata or Acanthus pubescens, which are difﬁcult to eat; and (4) urticant plants like Urera 
sp. Among the plant parts we collected that are eaten by chimpanzees, all but one (Celtis africana leaves) are 
consumed only infrequently and thus can not be considered as a major component of their nutritional intake 
according to long-term data (TABLE I). In addition to the plant parts speciﬁcally eaten by chimpanzees, 
we collected other parts from the same species.  This was done for comparison and to increase our general 
knowledge of the entire plant’s chemistry.  Plant specimens were identified with the help of field assistants, 
then compared and identified in the herbarium of the Laboratoire de Phanérogamie at the Museum National 
d’Histoire Naturelle (Paris, France). Plant material was sheltered from the sun and air-dried in the field.
Chemical analysis
The air-dried ﬁnely powdered plant material was extracted three times consecutively with ethyl acetate and 
methanol heated at 40°C for three hours. 84 crude extracts were made from the different parts of 24 plant species 
from 13 botanical families. The extracted solutions were concentrated in vacuo providing crude extracts. 
Thin Layer Chromatography (TLC), column chromatography and High Performance Liquid Chromatography 
(HPLC) were used to fractionate bioactive extracts and to isolate active compounds.  Spectroscopic analyses 
(1H-NMR, 13C-NMR, LC-MS, EI-MS, IR and UV) were employed to determine the chemical structures.
In vitro bioassays 
 Dried extracts dissolved in DMSO (Dimethyl Sulfoxide) were assessed for in vitro activities against 
the following parasites Leishmania donovani, Trypanosoma brucei brucei, Plasmodium falciparum and a 
free-living worm Rhabditis pseudoelongata with almost the same sensibility to Ivermectin as a parasite worm. 
Antitumor activities were assayed by measuring the cytotoxicity against KB cells from human tumor tissue. 
Extracts were also tested against bacteria (Staphylococcus aureus, Escherichia coli) yeast and fungi (Candida 
tropicalis, Penicillium crustosum). All the tests were conducted in duplicate or triplicate, and means of the 
assays are presented in the following results. The results are expressed as the concentrations inhibiting parasite 
or cells growth by 50% (IC50) or killing 50% of the population for worms LD50 (lethal dose 50%). 
 The anti-trypanosomal screening was carried out according to the method described by Loiseau et 
al. [2000].  Trypanosoma brucei brucei GVR 35/Cl.2 bloodstream forms were used for in vitro screening. 
Leishmania donovani (MHOM/IN/80/DD8) promastigote forms were used for in vitro screening. The 
antileishmania screening was performed according to the method described by Mbongo et al. [1997]. 
Antimalarial activity was tested against intra-erythrocytic asexual forms of the human malaria parasite 
Plasmodium falciparum, following the method of Desjardin et al. [1979]. We prepared an asynchrone culture 
of parasites [Trager & Jensen, 1976] with human serum containing parasitemia of 1% and a hematocrit of 
2%. For anthelmintic assay, Rhabditis pseudoelongata were isolated from wild rabbit feces and maintained 
on sterilized rabbit feces. They were recuperated from a 10 days old culture by the Baerman method. Worms 
isolated were larvae I, II, III and IV stage and male and female adults. Two-hundred worms were deposited in 
each of the 24 wells of the plate. Extracts in DMSO were added and the wells were ﬁlled up to 500 μl with sterile 
water. Motile and non-motile worms were counted and compared with the control wells. Cytotoxicity assays 
were conducted on KB cell line. The KB cell line was derived from an epidermoid carcinoma in the mouth of 
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an adult human [Eagle, 1955; Shoemaker et al., 1983]. A suspension of 75,000 cells in 2 ml of 199/bicarbonate 
medium was deposited in every well. Two control tests with solvent and adriblastine 10-7 M were prepared. 
Trays were incubated for 3 days. Two-hundred μl of neutral red were added and trays were incubated one more 
night. The day after, suspension was removed and the cells were washed rapidly with PBS and 1 ml of SDS 
was deposited in every well. The living cells incorporate neutral red, while the dead cells do not [Borenfreund 
& Puerner, 1985].  Absorbance of neutral red was measured with a 540 nm ﬁlter. Antimicrobial assays against 
bacteria, yeast and fungi were conducted following two steps; antimicrobial screening and evaluation of the 
Minimum Inhibition Concentration (MIC). Disks were soaked with 500 μg of extract in 20μl of methanol, 
dried and laid down in Petri boxes inundated with colonies in culture medium. They were incubated at 37°C 
for the bacteria and at 27°C for the fungi for 18 hours. The diameter of the inhibition zone was read. Bacteria 
used were Staphylococcus aureus ATCC 6538 (culture medium: Mueller-Hinton), Escherichia coli ATCC 
8739 (culture medium Mueller-Hinton) and fungi were Candida tropicalis ATCC 66029 (culture medium: 
Sabouraud) and Penicillium crustosum LCP 75.3045 (culture medium: Malt Agar extract). Extracts selected by 
this method for their activities were tested in liquid medium for antimicrobial activity against Staphylococcus 
aureus to determine MIC. Other microbial targets did not exhibit signiﬁcant activities. Extracts in DMSO and 
suspension of bacteria in exponential growth in Luria Bertoni medium (0,2nm<DO<0,4nm) were deposited in 
96 well trays.  Control tests were performed using DMSO and bacterial suspension.  Trays were incubated at 
30°C and shacked at 250 RPM for 18 hours.  Absorbency at 620 nm was measured. The lowest concentration 
of test extracts in which no growth occurred was deﬁned as MIC. The contents of the well were removed 
and cultured in Petri boxes using Mueller-Hinton medium to check the bactericidal or bacteriostatic activity. 
Growth of bacteria was examined after 48h by visual inspection.
Fractionation of bioactive extracts and isolation of pure products
According to the TLC results, we selected appropriate solvents to fractionate the crude extracts that 
appeared to be the most active, with the following speciﬁc methods:
(1) The crude methanol extract of Diospyros abyssinica bark was chromatographed on silica gel with 
heptane-ethyl acetate. Fractionation was bioguided by activities on Leishmania donovani. The active fractions 
were puriﬁed by HPLC (Thermo-Hypersil 250x21.2 mm 5 μ Kromasyl HS C18).
(2) Dried bark powder of Uvariopsis congensis was ﬁrst defatted with heptane then extracted with 
ethyl acetate. Crude ethyl acetate extract was fractionated on silica gel with heptane-acetone. Column 
chromatography with isopropanol-dichloromethane and HPLC (Thermo-Hypersyl 250x21.2mm 5 μ Kromasyl 
HS C18) on the more active fractions on KB cells were used to isolate compounds.
 (3) Puriﬁcation of the extract of the leaves of Uvariopsis congensis was performed by HPLC (Thermo-
Hypersyl 250x21.2mm 5 μ Kromasyl HS C18). 
(4) The methanolic extract of the bark of Albizia grandibracteata was partitioned with butanol-water 
and the butanol fraction was washed with ether.  Four fractions were separated with Sephadex LH 20. 
 (5) Crude ethyl acetate extract of leaves of Trichilia rubescens fractionation was bioguided by its 
antimalarial activity. The extract was chromatographed on silica gel with dichloromethane-methanol and the 
active fractions against P. falciparum were re-chromatographed with heptane-ethyl acetate.
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RESULTS
Pharmacological properties of plant parts ingested by chimpanzees
According to data that we reviewed from Chapman & Hall (2003), natural pure products have been 
isolated from 30 (25 %) of the species eaten by chimpanzees in the Kibale Forest showing that there is still 
little known about the chemistry of plants from their diet. Moreover, those compounds are not always extracted 
from the part ingested by the chimpanzees. 
Table II shows the most active extracts screened from a total sample of 84 plant parts collected from 24 
species ingested by Kanyawara chimpanzees. During the 3864 focal-animal sessions collected in the present 
study, chimpanzees were feeding or foraging for 47% of the time. Among the 46 plant items consumed in the 
present study, two of them were previously known to have pharmacological properties i.e. Antiaris toxicaria 
pith and leaves from which latex is used as dart poison and Phytolacca dodecandra berries, which contain 
bioactive saponins. The present pharmacological assays revealed three bioactive items (Albizia grandibracteata 
bark, Trichilia rubescens leaves and Ficus exasperata stems bark) consumed during the present study whose 
activities are reported hereafter and in Table II. All of these ﬁve items were consumed during less than 0.5% 
of the feeding time during our study period. 
 Of the 84 items tested, 45% (n= 38) were bark extracts. Bark extracts represent 63% of items exhibiting 
a signiﬁcant activity in the assays conducted. The difference between the two proportions is signiﬁcant 
(Fisher test P=0.04), consistent with our hypothesis that bark consumption may often be a high source of 
pharmacological compounds. However besides rarely eaten plant parts exhibiting signiﬁcant IC
50
 values, 
food plants with weaker IC
50
 values but consumed in larger quantities may also have an important long-term 
pharmacological effect. 
 Various different kinds of bioactivity were detected among the crude extracts investigated. Antiparasite 
activities were found for several plant extracts. Six crude extracts (7%) displayed noticeable antimalarial 
activity, i.e. their IC50 values were below 10 μg/ml. Three samples among those were extracted from plant 
parts eaten by chimpanzees.  Ethyl acetate and methanol crude extracts of Trichilia rubescens leaves and the 
ethyl acetate crude extract of Diospyros abyssinica bark had a signiﬁcant IC50 value against Plasmodium 
falciparum. The ethyl acetate crude extract of Diospyros abyssinica bark exhibited high anti-leishmania 
activity after 24h and 72h incubation time (IC50 =1μg/ml).  Ten crude extracts had a LD50 against Rhabditis 
pseudoelongata below 100 μg/ml.   
Antimicrobial activities against bacteria, yeast or fungi were investigated. An inhibition zone with 
a diameter of 12 mm or more was observed for 17 crude extracts and 11 of them were bactericidal against 
Staphylococcus aureus.  The MIC was below 25 μg/ml for four crude extracts.  Three crude extracts (bark of 
Mimusops bagshawei, Chrysophyllum albidum and Pancovia pedicellaris) had an inhibition diameter of 9 mm 
or more but less than 12 mm against Escherichia coli.  No extracts exhibited any signiﬁcant activity against 
Trypanosoma brucei brucei, Candida tropicalis or Penicillium crustosum. We noted that the methanol crude 
extract of Acanthus pubescens ﬂowers, which are not eaten by Kanyawara chimpanzees but consumed by 
Sonso chimpanzees [Pebsworth et al. in press] showed important anthelmintic activity at a range of 25 μg/ml 
to 50 μg/ml. Its ethyl acetate extract was bactericidal (antimicrobial screening with disks) and its MIC against 
S. aureus was 25 μg/ml. 
In vitro tests of the biological activity of six crude extracts showed more than 85% cytotoxic activity 
on human KB cells at 10 μg/ml.  Five crude extracts had an IC50 at or below 1 μg/ml, i.e. methanol crude 
extracts of Uvariopsis congensis bark and leaves, Albizia grandibracteata bark and leaves, and ethyl acetate 
crude extract of Diospyros abyssinica bark.
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TABLE II. Biological activities of plants species ingested by chimpanzees in Kibale National Park, Uganda
(IC50: inhibiting concentration 50%, LD 50: lethal dose 50%, in bold, most signiﬁcant activities) 
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 According to the results of biological screening, extracts from plant parts eaten by chimpanzees of 
Diospyros abyssinica, Albizia grandibracteata, Trichilia rubescens and Uvariopsis congensis, exhibited such 
high bioactivity that it leads us to strongly consider the chimpanzees selecting them had a criteria other 
than nutritive intake alone.  Such items are rarely ingested by Kanyawara chimpanzees, as was the case for 
those plant foods with medicinal value for the treatment of parasite related maladies in Mahale chimpanzees 
[Huffman et al., 1998].  For these reasons, we decided to further investigate the chemical content of the 
extracts.
Chemical investigations
In order to isolate the bioactive constituents of plants from the chimpanzee diet, we focused our 
chemical analyses on the four plant species exhibiting the most signiﬁcant biological properties; Diospyros 
abyssinica, Uvariopsis congensis, Albizia grandibracteata and Trichilia rubescens. 
(1) Fractionation of Diospyros abyssinica bark (rarely consumed by chimpanzees) yielded isodiospyrin 
and diospyrin (Fig. 1), two bisnaphtoquinones identiﬁed by NMR, LCMS, UV and IR spectroscopy.  Their IC50 
value against Leishmania donovani is 0.5 μM (IC50 L. donovani for the reference product: Pentamidine=7 μM). 
Their activity against Plasmodium falciparum was weaker (IC50=1.5 μM; IC50 chloroquine =0.1μM). 
  These quinones were previously isolated from other Diospyros species, and were known for their 
activities against protozoan parasites such as Leishmania donovani, Trypanosoma cruzi and Trypanosoma 
brucei brucei [Yardley et al., 1996]. They also showed inhibitory activities against murine tumors in vivo [Pal 
et al., 1996; Norhanom & Hazra, 1997] and inhibition of blood platelet aggregation [Kuhe et al., 1998].
(2) The activities against Plasmodium falciparum and KB cells of the crude extract of Uvariopsis 
congensis were investigated. The crude extract of dried bark powder was puriﬁed. One of the compounds 
isolated was identiﬁed by NMR, LC-MS and EI-MS methods as cis-annonacin, an acetogenin (Fig. 2). This 
compound was the most common product from the leaves, sporadically eaten by chimpanzees. Its IC50 on KB 
cells is 0.24 μM (IC50 on KB cells for the reference product: Adriblastine=0.1 μM). Gigantetrocine, another 
acetogenin potentially cytotoxic to tumoral cells (2.2 μM) was isolated.
Fig.1 Two bioactive bisnaphtoquinones isolated from the bark of Diospyros abyssinica 
(Ebenaceae), eaten by the chimpanzees of Kanyawara, Kibale NationalPark, Uganda.
Fig.2 A bioactive acetogenin, the annonacin, isolated from the leaves of Uvariopsis congensis (Annonaceae) 
eaten by the chimpanzees of Kanyawara, Kibale National Park, Uganda
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(3) The methanol extract of Albizia grandibracteata bark (as eaten by OK 20 October 2001) had 
anthelmintic activity against Rhabditis pseudoelongata and was cytotoxic (90% at 1 μg/ml) to KB cells. A 
mixture of saponins was contained in the active fraction. Three products have been isolated and are structurally 
novel saponins [Krief et al., in prep.]. 
(4) After fractionation of the crude ethyl acetate extract of Trichilia rubescens leaves, the anti-malarial 
activity increased up to 4 ng/ml. During this fractionation, novel limonoids, Trichirubines A and B, with high 
antimalarial activities were extracted and identiﬁed [Krief et al., 2004].
Chimpanzees ingestion of plants with bioactive compounds and their state of health
Most of the chimpanzees monitored during the 4 months of this survey appeared to be in good health or, 
at least, improved quickly after small injuries or ﬂu-like symptoms [Krief, 2003]. However, during the study 
period, at least 10 cases of patently ill chimpanzees were observed.  Five cases were respiratory infections 
with nasal discharge, sneezing and coughing, including two severe cases with lethargy, dyspnea and anorexia. 
Two chimpanzees were detected suffering from gastrointestinal disorders. Bacterial infections were diagnosed 
in one wounded chimpanzee (LB) and in another individual (TU) suffering from tooth abscess. An old female 
(LP) with severe abdominal distension also had a left hand injury.  The swollen hand was not used for tree 
climbing. 
These wounded or sick chimpanzees were closely monitored in the ﬁeld. Since the symptoms were 
totally absent after one week, we consider that all of them had recovered from their respective diseases. Their 
utilization of plants possibly with medicinal functions was examined in each instance (see following case 
studies).
 Fecal samples showed the presence of parasites, with 93% and 95% prevalence for feces collected in 
the dry and the rainy season respectively. However, 96% of the samples had less than 1000 parasites per gram 
[Krief et al., 2003]. This corresponds to a low parasitic load for humans [Hercberg et al., 1986].
Among the 10 case studies of chimpanzee ill health presented in TABLE III, we selected two because 
of their particularly clear diagnosis and because it was possible to make sufﬁciently continuous observations 
to test the hypothesis of a potential effect of plants on health.  They are as follows. 
Fig.3 Antimalarial compounds, Trichirubines A and B, from the leaves of Trichilia rubescens (Meliaceae) 
ingested by the chimpanzees of Kanyawara, Kibale National Park, Uganda
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(1) On 15 February 2001, a ﬁght was observed between two adult males, YB and LB. YB bit LB’s 
foot. The 5th toe was severely cut, hanging from his foot by only a strip of skin.  On 19 February, 
LB’s locomotion appeared to be painful, and the following day, his toe was black and dry.  The 
wound on the edge of his foot grew to be 1cm deep, 4cm wide. Nine days after the aggression, 
LB’s toe fell off and the wound looked clean. LB’s diet during this period contained 5 plants 
typically used in traditional medicine for wounds and other ailments in humans and domestic 
animals (TABLE IV). None of them were unusual dietary items, excepted the young leaves and 
stems of Ficus exasperata. Four chimpanzees from the same party were feeding on other items 
during his F. exasperata ingestion. We investigated the chemistry of three of these species to test 
whether or not they could have aided the recovery of LB’s wound (results in TABLE III). Disks 
soaked with an ethyl acetate extract of Ficus exasperata bark are bacteriostatic, and leaves and 
stems of this species were eaten by the wounded chimpanzee.
(2) Starting about 16 October 2001, OK, a 6-year-old female, suffered from an intestinal disorder, 
evidenced by her producing alternately dry, soft and diarrheic stools. Fecal analysis revealed a 
high load of parasitic infection (strongyle species and Probstmayria gombensis) [Krief et al., 
2003]. We observed OK eating Albizia grandibracteata bark at 9:42 on 20 October 2001. This 
was the ﬁrst recorded time since the observations began in Kanyawara in 1987 that a chimpanzee 
had been seen to consume the bark of this species, though they have occasionally been observed 
eating its leaves. OK was the only one of the group to eat the bark. She ate it for 3 minutes while 
her mother and siblings were waiting for her. Feces collected two days after OK’s ingestion of 
A. grandibracteata bark (October 22) had a normal consistency and the parasitic load was nil. 
TABLE IV. Ethnomedicinal information on plants ingested by a wounded chimpanzee (LB) in the Kibale 
National Park, Uganda (UPU : unknown part used, DRC : Democratic Republic of Congo, CAR : Central 
Africa Republic) 
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Albizia grandibracteata bark is traditionally ingested as a medicine in Uganda and in Democratic 
Republic of Congo (DRC) against intestinal parasites and bloat [Heine & Konig, 1988; Defour 
1994]. This observation raises the possibility that OK’s bark-eating was responsible for reducing 
the high parasite load and digestive symptoms seen since October 16.
Regular presence of bioactive compounds in the diet
Among unusual behaviors, we have observed that Kanyawara chimpanzees feed occasionally on 
Trichilia rubescens leaves. Such consumption bouts were short (from 1 to 21 minutes for our 21 observations, 
mean: 5 minutes) and infrequent (chimpanzees were observed to ingest these plant species from from 0 to 
4 times per month across the 8 months of observation). Only a few leaves were eaten each time (ca. 7/
minute). This plant generally grows in a cluster so that leaves would be available for several chimpanzees. 
For each observation made, usually only one chimpanzee, rarely more, ate this item while in a group of 2 - 28 
individuals. On two occasions, chimpanzees were observed ingesting 100 leaves or more at a time. In one case 
(11/06/2003), a wounded chimpanzee (AJ) consumed more than 100 leaves from 7:37 to 7:58 in the morning. 
Twelve minutes later, ST was observed feeding on Trichilia rubescens leaves (about 20).  ST was observed 4 
weeks later ingesting around 100 leaves without any observable or measurable symptoms. He was observed 
by LK, who was tasting a few leaves of the item. In one case, one individual (MS, 12/22/2003) was ingesting 
many leaves (60), observed by 3 individuals (BB, ST, TU) who did not consume the item.  On 25th March 
2004, UM changed her travel route to consume a few leaves of this plant.  Two minutes later, MS consumed 
17 leaves. During the 8-month study period, three individuals were observed to ingest the plants on multiple 
occasions (MS: 3 times, AJ: 3 times, ST: twice). In each case the chimpanzee left the Trichilia shrub before 
having eaten all the leaves of the tree, except AJ who consumed leaves from 2 trees on the 6th November 
2003. These observations lead us to strongly suggest that chimpanzees eating Trichilia rubescens leaves may 
provide beneﬁts other than nutritional as usually only small amount are consumed. Signiﬁcant anti-malarial 
activities on the human protozoan parasite, Plasmodium falciparum, have been demonstrated for the crude 
extracts and two novel limonoids having a CI
50
 roughly equivalent to chloroquine have been isolated [Krief et 
al. 2004]. The human parasite is very similar to P. reichenowi, which occurs in west, central and east tropical 
Africa and affects gorillas and chimpanzees [Töft, 1986]. The several species of Plasmodium affecting great 
apes are generally considered as mildly pathogenic but few details have been reported in wild individuals 
[Töft, 1986]. No symptom that might be related to malaria were detected among chimpanzees in the present 
study. More accurate diagnosis is needed for detecting discrete symptoms. In one case, a larger amount was 
consumed by a wounded chimpanzee. In addition, Trichilia rubescens is easily confused with a closely related 
species, T. dregeana. Thus, Trichilia rubescens was previously identiﬁed as T. dregeana in Kibale National 
Park.  Accordingly, it is noteworthy that Trichilia dregeana bark is used in traditional Zulu medicine to treat 
headaches or inﬂammatory diseases [Jäger et al., 1996].  Among 39 ethanolic plant extracts tested by Jäger et 
al. [1996], Trichilia dregeana showed high inhibitory activity for prostaglandin-synthesis. Prostaglandins are 
involved in the process of inﬂammation and are responsible for the feeling of pain. Such properties may have 
beneﬁted the wounded chimpanzee, the pain felt by the chimpanzee being related to the increased amount 
consumed of a plant with analgesic effect. 
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DISCUSSION
Results of the biological screening of plant parts eaten by chimpanzees demonstrated that some 
items ingested only rarely possess very signiﬁcant pharmacological properties. This suggests that there may 
be motivational factors additional to nutritional value for choosing certain food items.  Other plant parts 
exhibited weaker effects, which may act by cumulative effect or repeated ingestion. As suggested by Lozano 
[1998], there may be two aspects of self-medicative behavior, i.e. preventive and therapeutic. Without passing 
judgment here on whether the ingestion of some plants with a preventative function are conscious acts, it 
seems clear to us that the consumption of some plants with minimal nutritional beneﬁts taken at low levels 
in the regular diet by individuals may act to prevent the risk of parasitism or infection and maintain a low 
level of pathogens. This study provides further new evidence that chimpanzees forage on some plants also 
used in human and veterinary traditional medicine [Huffman et al., 1996a; 1998a]. Among the 117 plant 
species known to be ingested by chimpanzees in the Kibale Forest from long-term records, at least 27 (23%) 
are used in traditional African medicine according to published references and data available on websites 
[review in Krief, 2003; Krief et al. in prep.]. Even though the plant parts used by healers is often not included 
in the descriptions of the preparation, we found uses in traditional medicine for 35 of the 163 parts ingested 
by chimpanzees in Kanyawara. While a larger sample set including plants regularly eaten is necessary to 
demonstrate a correlation between the rate of consumption and bioactivities of the plant species, we do not 
believe that every species chimpanzees ingest has some kind of biologically active property.  Cases of Albizia 
grandibracteata consumption related to intestinal disorder and increase of Trichilia rubescens consumption 
by a wounded chimpanzee provide evidence that ingestion of plants with medicinal properties is not just a 
random event and very well may be driven by a desire for certain secondary plant compounds.   In the future, 
other properties such as anti-inﬂammatory activity would be interesting to screen.  
The non-invasive health monitoring used during this study is a viable way to test the hypothesis of 
a regulation process induced by plant antiparasitic activities or immunostimulating properties of natural 
compounds. Thus, four points are consistent with the hypothesis that elements of the chimpanzees’ diet can 
contribute to reducing the effect that parasites and microbes have on their health : (1)  Some items ingested 
by chimpanzees are also common to traditional African medicine, (2) Chimpanzees showed a relatively low 
parasite load, (3) Most of the Kanyawara chimpanzees were in relatively good health as evaluated by urinalysis, 
fecal analysis and veterinary observations [Krief, 2003], (4) The results of biological property screening were 
conﬁrmed by the isolation of pure bioactive compounds.  It would be interesting to conduct similar studies on 
other primate species in the region. 
The related observations of ill or wounded chimpanzees were consistent with the hypothesis that 
they beneﬁted from the use of some plants with bioactive properties. Such plants are also used by the local 
population to treat similar symptoms [sic. Huffman & Wrangham, 1994; Huffman et al., 1996; Huffman et al. 
1998b].  For example, the diet of LB, when he was wounded, contained Ficus exasperata stems and leaves. 
Bark of stems have antibacterial properties and leaves are used in Africa to cure cutaneous infections and to 
relieve pain in humans and livestock [Bouquet, 1969]. Leaves of Ficus exasperata have also been prescribed 
as an anti-ulcer remedy; and a study on rats revealed that the extract of these leaves shows signiﬁcant anti-
ulcerogenic properties [Akah et al., 1998].  In addition, F. exasperata (parts tested not described) has already 
shown antitumor activities and remarkable inhibition of trypsin activity [Koshimizu et al., 1993]. These points 
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suggest to us that LB’s health could have been improved by the inclusion in his diet of some of these plants 
containing bioactive compounds. 
The unusual feeding behavior on Trichilia rubescens leaves led us to the discovery of its interesting 
antimalarial activity. No symptom related to an infectious disease such as malaria was detected in chimpanzees 
ingesting this item, but malaria in apes is known to be sub-clinical or mildly pathogenic. Nevertheless, when 
coupled with other diseases, malaria may become deleterious [Skinner and Hopword, 2004].  Malaria was 
examined as the cause of linear enamel hypoplasia in apes by Skinner et al. [1995] and Guatelli-Steinberg and 
Skinner [2000]. In a recent survey on the prevalence of malaria in wild born, ex-captive Bornean orangutans, 
M.J. Reid and colleagues (pers. comm.) found that more than 25% of the individuals tested were infected by 
a Plasmodium parasite. Such clues suggest that pathogen pressure may be reduced by the ingestion of certain 
plants.  This hypothesis was most clearly implied in the case when OK ate bark of Albizia grandibracteata while 
suffering from intestinal upset and had a heavy parasitic load. This unusual dietary item apparently increased 
OK’s intake of compounds that were bioactive against helminths, because we found that A. grandibracteata 
bark contained bioactive saponins. Subsequently, OK’s condition improved, and fecal examination conﬁrmed 
reduced parasitism in vivo. These observations conform to the apparent importance of Albizia grandibracteata 
bark as a traditional medicine. 
While OK’s case suggests that her diet was effectively medicinal, further work will be required to 
prove it. First, chemical extractions with methanol or ethyl acetate solvents exclude the digestion process 
from pharmacological testing. Second, detoxiﬁcation mechanisms could interfere with potential medicinal 
properties. Third, we need to quantify the amount of each plant consumed to estimate what bioactivity level 
may be expected in the chimpanzee’s body. As proposed by Huffman [2003], the next step will be to conduct 
in vivo tests to determine efﬁciency of different plants parts in suppressing different pathogens relevant to 
chimpanzees.
According to the results of our in vitro tests, several plant species ingested by chimpanzees are active 
against human pathogens. Some of these agents, such as Staphylococcus aureus or Escherichia coli, can affect 
both humans and chimpanzees.  In such instances the observation of chimpanzees choosing bioactive plant 
products supports the self-medication hypothesis. However, additional tests are needed for pathogens speciﬁc 
to chimpanzees, in spite of the phylogenetic proximity.  Finally, even if medicinal activity is supported by 
further data, we acknowledge that in the case of plant parts that provide nutrients and minerals, it is difﬁcult 
to assess the relative importance of nutritional signals, versus cues of bioactivity or painkilling, as inﬂuences 
on chimpanzee food choice. 
In conclusion, this study shows that the chimpanzee diet includes compounds likely to offer medicinal 
beneﬁts, including reducing the level of pathogens and keeping chimpanzee health problems to a sub-clinical 
level. Among the implications of the survey of chimpanzee diet, feeding behavior and health may lead to 
ﬁnding new natural products with potential medicinal properties for human beings. Such a diet may allow 
chimpanzees to maintain a good state of health and to prevent illness while avoiding potential toxicity and 
resistance induced by repeated consumption.  Some plants with stronger biological properties are consumed in 
small quantities and only on rare occasions and thus are likely of curative value. Between these two mechanisms, 
we should consider that health is a continuum and the positive feedback of a medicinal substance may act 
during the sampling of the regular diet by an individual feeling weak discomfort.  Therapeutic medication may 
also be learned individually and food aversion may be attenuated by observation of conspeciﬁcs feeding on 
this item. 
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At a conference at the Max Planck Institute in Leipzig in 2004, where the network GAHMU (Great 
Apes Health Monitoring Unit) was created, disease was considered as the third major threat for great ape 
populations today. Habitat destruction, caused by opening roads into the forest, has a major impact not only 
by facilitating poaching and the bushmeat trade but also by enhancing the potential for pathogen introduction 
and transmission. Environmental disruption may change the balance between host and pathogens by depriving 
animals of important plants that provide both essential nutrients affecting immunologic status and secondary 
compounds that might help to ﬁght against diseases. The effect on animals’ health from deprivation of the 
diversity of secondary compounds is today probably underestimated because the actual medicinal value of 
plants is still unknown in most of the habitat of primates. Such a pharmacological approach to the study of 
their diet might also be a valuable new tool for primate conservation. 
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